Massive chart review aims to unravel cachexia in lung and GI cancers
NCT ID NCT03606317
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the medical records of 20,000 patients with lung or gastrointestinal cancer who also have cachexia (severe weight loss and muscle wasting). The goal is to learn how cachexia is currently managed and what factors affect patient outcomes. No treatments or tests are given; researchers simply analyze existing data from two hospitals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better understand how cachexia progresses and how it is currently managed, pointing toward improved care guidelines.
What could go wrong
This is a retrospective chart review, not a treatment trial. It cannot prove what works best, only describe past practices. Results may not apply to other hospitals or patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.